No Data
No Data
Zhejiang Garden Biopharmaceutical Co.,Ltd. (SZSE:300401) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing
Zhejiang Garden Biopharmaceutical: Summary of Half-Year Report in 2024.
Zhejiang Garden Biopharmaceutical: Half-year report for the year 2024.
Zhejiang Garden BiopharmaceuticalLtd (SZSE:300401) Has A Somewhat Strained Balance Sheet
Zhejiang Garden Biopharmaceutical (300401.SZ): The price of the main raw material for Vitamin D3 production is currently fluctuating slightly.
On July 26, Gelunhui reported that an investor asked Zhejiang Garden Biopharmaceutical (300401.SZ) on the investor interaction platform, "Has the production material for vitamin D3 increased in price?" The company replied that the main production material for vitamin D3 has currently experienced only minimal price fluctuations.
Zhejiang Garden Biopharmaceutical Co.,Ltd.'s (SZSE:300401) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
No Data
No Data